Vivo Capital’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332M | Sell |
3,958,294
-500,000
| -11% | -$41.9M | 33.94% | 1 |
|
|
2025
Q1 | $319M | Sell |
4,458,294
-1,833,557
| -29% | -$131M | 42.19% | 1 |
|
|
2024
Q4 | $283M | Hold |
6,291,851
| – | – | 31.68% | 1 |
|
|
2024
Q3 | $318M | Sell |
6,291,851
-1,025,000
| -14% | -$51.8M | 26.29% | 1 |
|
|
2024
Q2 | $299M | Sell |
7,316,851
-1,101,242
| -13% | -$44.9M | 27.58% | 1 |
|
|
2024
Q1 | $360M | Hold |
8,418,093
| – | – | 28.31% | 1 |
|
|
2023
Q4 | $339M | Buy |
8,418,093
+5,215,000
| +163% | +$210M | 27.74% | 1 |
|
|
2023
Q3 | $94.5M | Buy |
+3,203,093
| New | +$94.5M | 10.36% | 2 |
|
|
2020
Q2 | – | Sell |
-134,758
| Closed | -$4.81M | – | 57 |
|
|
2020
Q1 | $4.81M | Buy |
+134,758
| New | +$4.81M | 0.44% | 41 |
|
|
2019
Q3 | – | Sell |
-284,597
| Closed | -$12M | – | 26 |
|
|
2019
Q2 | $12M | Sell |
284,597
-6,049
| -2% | -$254K | 1.12% | 24 |
|
|
2019
Q1 | $8.98M | Hold |
290,646
| – | – | 0.9% | 29 |
|
|
2018
Q4 | $7.46M | Hold |
290,646
| – | – | 0.95% | 27 |
|
|
2018
Q3 | $9.42M | Hold |
290,646
| – | – | 0.95% | 27 |
|
|
2018
Q2 | $10.2M | Buy |
290,646
+21,744
| +8% | +$763K | 1.31% | 21 |
|
|
2018
Q1 | $7.31M | Hold |
268,902
| – | – | 1.04% | 20 |
|
|
2017
Q4 | $7.26M | Buy |
268,902
+72,965
| +37% | +$1.97M | 1.56% | 17 |
|
|
2017
Q3 | $7.64M | Hold |
195,937
| – | – | 1.54% | 16 |
|
|
2017
Q2 | $7.36M | Hold |
195,937
| – | – | 1.85% | 12 |
|
|
2017
Q1 | $10.4M | Buy |
195,937
+96,511
| +97% | +$5.14M | 3.07% | 9 |
|
|
2016
Q4 | $6.04M | Hold |
99,426
| – | – | 1.99% | 14 |
|
|
2016
Q3 | $6.71M | Hold |
99,426
| – | – | 2.09% | 13 |
|
|
2016
Q2 | $8.65M | Sell |
99,426
-125
| -0.1% | -$10.9K | 2.36% | 10 |
|
|
2016
Q1 | $8.89M | Buy |
+99,551
| New | +$8.89M | 2.23% | 13 |
|